(Q54690515)
Statements
Phase II study of erlotinib for chemotherapy-naïve patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum doublets. (English)
1 reference
Cheolwon Suh
1 reference
Dae Ho Lee
1 reference
Sang-We Kim
1 reference
Yun Hee Han
1 reference
Jung-Shin Lee
1 reference
25 February 2010
1 reference
67
1 reference
1
1 reference
35-39
1 reference
Identifiers
1 reference